Daily Bulletin

Men's Weekly

.

Zuellig Pharma and Institut AllergoSan sign 10-year regional partnership to bring leading probiotic brand OMNi-BiOTiC® to key markets in Asia

New agreement marks major milestone for Zuellig Pharma as it focuses on expanding its consumer healthcare segment, and for Institut AllergoSan as it expands its global presence

SINGAPORE - Media OutReach Newswire - 19 July 2024 - Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has signed a 10-year commercialisation partnership with Austria-based Institut AllergoSan, a research and development company that specialises in products made from natural substances such as probiotic bacteria, plant extracts and minerals.

Business News

How to Choose the Right Industrial Air Compressor for Your Business

Running a business is all about making the right decisions. When it comes to choosing an industrial air compressor, that decision becomes even more critical. Air compressors are long-term investment...

Daily Bulletin - avatar Daily Bulletin

Manhari Founder, Maddy Gupta, urges businesses to capitalise on the rising value of metals

Old and unwanted equipment and business assets are often worth far more than they appear particularly those containing valuable metals. Precious metals, led by gold and silver reaching record highs...

Daily Bulletin - avatar Daily Bulletin

Qualities to Check in an NDIS Provider

Everyone wants to live life with independence and dignity. For people with disabilities, achieving this often requires the right support. This is where NDIS providers play an important role. These pro...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business